Stephen Gwaltney

Stephen Gwaltney

Company: SpringWorks Therapeutics

Job title: Head of Drug Discovery


Discovery & Development of Novel YAP/TAZ-TEAD Antagonists 10:00 am

Activity of the YAP/TAZ-TEAD complex represents a compelling pharmacologic target We have identified novel small molecules that bind to the TEAD autopalmitoylation pocket; these compounds are highly potent, orally bioavailable and active against multiple cancer cell lines In vivo models of Hippo pathway-altered xenografts showed that our inhibitors deliver consistent monotherapy activity, with dose-dependent and…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.